ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Role of ALPK1 in Inhibiting Hepatitis B Virus Replication Facilitates the Identification of ALPK1 P660L Variant for Predicting Response to Pegylated Interferon α Therapy

Lou, Shuang; Wang, Jialin; Chen, Jiaxuan; Xie, Haisheng; Chen, Haitao; Zhou, Bin; Zhang, Bo; Hou, Jinlin; Jiang, De-Ke*南方医科大学; 中山大学
JOURNAL OF INFECTIOUS DISEASES2023-9-15DOI: 10.1093/infdis/jiad065
6阅读
引用收藏
分享

摘要

Background. Alpha kinase 1 (ALPK1) agonist has recently been reported to demonstrate anti-hepatitis B virus (HBV) efficacy via activating NF-kappa B signaling, which is crucial for maximizing interferon (IFN) responses. Here, we investigated the impact of ALPK1 on HBV replication and explored ALPK1 variants for predicting the response to pegylated IFN-alpha (PegIFN-alpha) treatment. @@@ Methods. The potential anti-HBV effect of ALPK1 was evaluated in HBV-integrated and HBV-infected hepatoma cells. The potentially functional genetic variants of ALPK1 were screened out, and their correlations with PegIFN-alpha treatment response were assessed in 945 hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B (CHB). @@@ Results. We revealed that ALPK1 inhibited HBV replication in hepatocytes via activating the JAK-STAT pathway. ALPK1 overexpression improved the anti-HBV effect of IFN-alpha in cell models. A missense variant, rs35389530 (P660L), of ALPK1 was strongly associated with combined response (CR; namely, HBeAg seroconversion and HBV DNA level <3.3log(10) IU/mL) to PegIFN-alpha treatment in patients with CHB (P = 2.12 x 10(-6)). Moreover, a polygenic score integrating ALPK1_rs35389530 and 2 additional genetic variants was further significantly associated with CR (P-trend = 9.28 x 10(-7)), hepatitis B surface antigen (HBsAg) level (P-trend = .0002), and HBsAg loss (P-trend = .025). @@@ Conclusions. The anti-HBV effects of ALPK1 through activating JAK-STAT pathway provides a new perspective for CHB therapy. ALPK1_rs35389530 and polygenic score are potential biomarkers to predict PegIFN-alpha treatment response and may be used for optimizing CHB treatment.

学科与关键词

关键词
ALPK1single-nucleotide polymorphismchronic HBV infectionPegIFN-alphatreatment response
相关
加载中…
  • Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients
    Chen, Jiaxuan; Hou, Jia; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Clinical Pharmacology and Therapeutics, 2024, 115(2): 361-370.
  • A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
    Li, Jing; Chen, Haitao; Chen, Jiaxuan; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Pharmacogenomics and Personalized Medicine, 2021, 14: 1505-1515.被引 5
  • An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients
    Hou, Jia; Dong, Chao; Chen, Jiaxuan; Chen, Haitao; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Antiviral Research, 2023, 220: 105741.
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF INFECTIOUS DISEASES
发表日期
2023-09-15
卷期
第 228 卷, 第 6 期
页码
694-703
DOI
10.1093/infdis/jiad065
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2022YFC2303600]; National Natural Science Foundation of China [82272765, 81670535, 81472618]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Natural Science Foundation of Guangdong Province [2019A1515011423]; Innovative Research Team Project of Guangxi Province [2017GXNSFGA198002]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2017J001]

作者

  • L

    Lou, Shuang (第一作者)

    youjiang med univ nationalities · southern med univ

  • W

    Wang, Jialin

    southern med univ

查看全部 9 位作者收起作者
  • C

    Chen, Jiaxuan

    southern med univ

  • X

    Xie, Haisheng

    southern med univ

  • C

    Chen, Haitao

    sun yat sen univ · southern med univ

  • Z

    Zhou, Bin

    southern med univ

  • Z

    Zhang, Bo

    southern med univ

  • H

    Hou, Jinlin

    southern med univ

  • J

    Jiang, De-Ke (通讯)

    southern med univ · youjiang med univ nationalities

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417